Elevance Health, Inc. (ELV) on Wednesday revised its annual earnings outlook.
Gail K. Boudreaux, CEO of Elevance Health, said: "We are raising our full-year adjusted EPS guidance, supported by greater visibility into the balance of the year. Our actions are driving more consistent performance and position Elevance Health for continued improvement over time."
For fiscal 2026, Elevance Health now anticipates a net income of at least $19.85 per share, including the company's estimate of the financial impact for the CMS matter.
The company now projects an annual adjusted profit of at least $26.75 per share, supported by underlying business strength, actions to reduce medical costs, and increased visibility.
Earlier, for fiscal 2026, Elevance Health had projected a net income of at least $22.30 per share, with an adjusted income of at least $25.50 per share.
The board will pay a second quarter dividend of $1.72 per share on June 25 to the shareholders of record as of June 10.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.